In the News

Novel Cancer Vaccine May Improve Survival in Synovial Sarcoma

Investigators are hopeful that CMB305, a vaccine that boosts the immune response to tumor cells expressing the antigen NY-ESO-1, can improve survival outcomes for patients with synovial sarcoma, a rare subtype of soft tissue sarcoma that primarily develops…

onclive.com. Jun. 26, 2018

View Article

 

Immuno-Oncology: Dr. Seth M. Pollack

Seth M. Pollack, MD, of the Fred Hutchinson Cancer Research Center, discusses immunotherapy for sarcoma, including Immune Design’s immunotherapy for synovial sarcoma, and how varying microenvironments in sarcoma subtypes impact response to immunotherapy.

ASCO Daily News. Jan. 22, 2018

Listen to Podcast

 

VACCINE FOR SARCOMA REPROGRAMS IMMUNE SYSTEM – (VIDEO NEWS STORY)

Doctors have created a vaccine that is showing some impressive results in a phase one trial, with few minor side effects.

Ivanhoe Broadcast News – Medical Breakthroughs. December 12, 2017

View Video, Research Summary and Doctor Q&A

 

Teacher, mom – and living proof of principle

Three years ago she was out of options to treat her advanced cancer. Then, she enrolled in an immunotherapy clinical trial.

Fred Hutch News Service. September 8, 2017

View Article

 

Revolutionary Thinking Required

Novel Targets Podcast. Bringing Science to Life. September 1, 2017

Listen to Podcast

 

Immune Design’s quest for a cancer vaccine could go the distance.

MarketWatch. August 28, 2017

View Article

 

Using a virus to teach the immune system to kill cancer

‘Exciting’ results from early trial spurts further development of novel vaccine for sarcoma

Fred Hutch News Service. June 2, 2017

View Article

 

Deploying an ancient defense to kill cancer

In a small sarcoma trial, signs of immune attack after injections of a bacteria-inspired drug

Fred Hutch News Service. April 3, 2017

View Article

 

And then there were five

Doctors are trying – with some success – to recruit the immune system to help with the war on cancer

The Economist. June 6, 2015

View Article